Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
Emerson Electric (EMR) vs Eaton (ETN): Stability Meets Surging Demand in Industrial Markets

Emerson Electric (EMR) vs Eaton (ETN): Stability Meets Surging Demand in Industrial Markets

Key Takeaways

  • EMR delivered steady, broad-based growth, with underlying orders up 14% in its latest quarter and a sixth consecutive year of double-digit adjusted earnings per share (EPS) growth.
  • ETN is growing revenue far faster, up 28% in its most recent quarter on surging data center and electrification demand, but its shares recently pulled back on valuation and margin concerns.
  • The two companies serve overlapping secular themes—automation, electrification, and energy—yet carry different risk profiles: EMR skews toward stability, while ETN skews toward higher-growth, higher-multiple exposure.
  • Tickeron AI Verdict: based on trend consistency, margin stability, and relative positioning, the AI would currently favor EMR over ETN.
  • For more detail on each company's latest developments and daily price action, explore EMR Major News and EMR Today's Price Move, as well as ETN Major News and ETN Today's Price Move.
  • To see how automated systems are positioning across these and thousands of other tickers, explore the curated Trending AI Robots.

Setting the Stage for EMR and ETN

Emerson Electric (EMR) and Eaton Corporation (ETN) rank among the largest industrial technology and power management companies in the U.S. market. Both stand at the intersection of electrification, energy security, data center expansion, and industrial automation, though they pursue growth along distinct paths. This comparison matters for investors assessing relative performance between a more consistent automation player and a faster-expanding electrical equipment provider. Their recent momentum, margin trends, and exposure to long-term demand themes offer useful perspective on which profile fits prevailing conditions.

Emerson Electric's Consistent Track Record

Emerson Electric operates as a global automation leader based in St. Louis, providing software-defined control systems, intelligent devices, and test and measurement solutions for process and discrete industries. In its most recent reporting, EMR posted quarterly revenue growth of roughly 7% and underlying orders up 14%, driven by long-cycle projects in power, LNG, semiconductors, and aerospace and defense. I also checked this using Tickeron’s AI Trend Prediction Engine to confirm the upward trajectory. Demand has broadened across regions and segments, supported by a growing project pipeline and solid execution. The company achieved its sixth straight year of double-digit adjusted EPS growth, expanded adjusted segment margins, and generated strong free cash flow. Management raised the dividend for the 71st consecutive year and signaled plans to return about $3.8 billion to shareholders, underscoring the stock’s stability profile. Shares have traded near the upper end of their 52-week range.

Eaton's Accelerated Momentum

Eaton Corporation, headquartered in Dublin, Ireland, focuses on intelligent power management with electrical equipment, aerospace systems, and vehicle components serving data center, utility, industrial, and commercial markets. In its latest quarter, ETN reported record revenue growth of roughly 28% year over year, with organic growth near 19% and adjusted EPS up about 20%, fueled by strong data center and electrification demand. Electrical orders and backlog hit records, with data center orders more than doubling on a rolling 12-month basis. The company has pursued acquisitions such as Boyd Thermal for data center cooling and Ultra PCS in aerospace, while planning to spin off its Mobility segment. Despite the strong results, shares pulled back over the prior three months amid concerns over valuation multiples and margin pressure from commodity costs and factory expansions. I reviewed order trends here with Tickeron’s AI Pattern Search Engine for additional context.

Head-to-Head: Growth Profile Versus Stability

The clearest distinction lies in growth speed versus consistency. ETN has delivered much faster revenue expansion, propelled by the data center build-out and grid modernization, yet it faces higher execution and valuation risks as it integrates acquisitions and scales capacity. Heavier acquisition-related debt has increased interest expense, keeping GAAP EPS growth below adjusted levels. EMR advances at a more moderate pace but with greater consistency across diversified markets, steadier margin expansion, and a clearer capital-return narrative. Sector exposure differs as well: EMR tilts toward process automation, energy, and industrial software, while ETN emphasizes electrical infrastructure and data center demand. Market positioning shows EMR maintaining stronger recent price stability near highs, whereas ETN has seen a notable drawdown despite robust fundamentals, reflecting market repricing of its premium valuation.

AI-Assisted Assessment of the Two Names

Considering factors such as trend consistency, margin stability, catalysts, and relative positioning, Tickeron’s AI currently leans toward EMR as the more favorable of the two. The view stems from EMR’s steadier upward trend, broad-based order growth, improving margins, and predictable shareholder returns, compared with ETN’s faster yet more volatile growth and recent price weakness. This remains a probabilistic assessment rather than a definitive recommendation; both companies benefit from strong secular tailwinds, and sustained data center acceleration could tilt the balance back toward ETN. The conclusion reflects current conditions only.

Using AI Tools for Portfolio Insights

One resource I turn to regularly when comparing names like these is Tickeron’s Trending AI Robots. It curates the strongest-performing automated strategies from hundreds of AI trading bots that monitor thousands of tickers, each with distinct styles, timeframes, and track records. Reviewing quantitative performance data there helps align strategies with prevailing market regimes and offers a data-driven complement to fundamental analysis across holdings such as EMR and ETN.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EMR, ETN

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


EMR's Stochastic Oscillator is sitting in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

EMR moved above its 50-day moving average on November 18, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 219 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 164 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.

Bearish Trend Analysis

The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 21 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EMR as a result. In 57 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for EMR turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 22 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.444) is normal, around the industry mean (3.843). P/E Ratio (35.370) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.015) settles around the average of (0.032) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (189.487).

Notable companies

The most notable companies in this group are Illinois Tool Works (NYSE:ITW), Ingersoll Rand (NYSE:IR), Generac Holdings (NYSE:GNRC).

Industry description

The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.

Market Cap

The average market capitalization across the Industrial Machinery Industry is 14.48B. The market cap for tickers in the group ranges from 3.71K to 242.5B. SIEGY holds the highest valuation in this group at 242.5B. The lowest valued company is SPEC at 3.71K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Machinery Industry was -7%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -21%. FISN experienced the highest price growth at 31%, while INLF experienced the biggest fall at -68%.

Volume

The average weekly volume growth across all stocks in the Industrial Machinery Industry was -55%. For the same stocks of the Industry, the average monthly volume growth was 42% and the average quarterly volume growth was 21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 49
Price Growth Rating: 62
SMR Rating: 69
Profit Risk Rating: 75
Seasonality Score: -4 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of process controls systems, valves and analytical instruments

Industry IndustrialMachinery

Industry
Electrical Products
Address
8027 Forsyth Boulevard
Phone
+1 314 553-2000
Employees
71000
Web
https://www.emerson.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.